KD Logo

Pacira BioSciences Inc’s latest rating changes from various analysts

Pacira BioSciences Inc’s filing revealed that its Chief Administrative Officer WILLIAMS KRISTEN unloaded Company’s shares for reported $0.21 million on Jun 13 ’24. In the deal valued at $28.38 per share,7,452 shares were sold. As a result of this transaction, WILLIAMS KRISTEN now holds 102,912 shares worth roughly $2.89 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, GAUGLER DARYL sold 1,000 shares, generating $28,380 in total proceeds. Upon selling the shares at $28.38, the Chief Operating Officer now owns 116,040 shares.

Before that, HASTINGS PAUL J sold 880 shares. Pacira BioSciences Inc shares valued at $24,974 were divested by the Director at a price of $28.38 per share. As a result of the transaction, HASTINGS PAUL J now holds 12,724 shares, worth roughly $0.36 million.

A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in mid December with a ‘”an Outperform”‘ rating. TD Cowen also remained covering PCRX and has increased its forecast on August 03, 2023 with a “an Outperform” recommendation from previously “Market perform” rating.

Price Performance Review of PCRX

On Friday, Pacira BioSciences Inc [NASDAQ:PCRX] saw its stock fall -0.85% to $28.13. Over the last five days, the stock has lost -1.54%. Pacira BioSciences Inc shares have fallen nearly -16.63% since the year began. Nevertheless, the stocks have fallen -27.39% over the past one year. While a 52-week high of $41.65 was reached on 01/08/24, a 52-week low of $25.33 was recorded on 04/26/24. SMA at 50 days reached $28.49, while 200 days put it at $29.98. A total of 0.61 million shares were traded, compared to the trading of 0.74 million shares in the previous session.

Levels Of Support And Resistance For PCRX Stock

The 24-hour chart illustrates a support level at 27.84, which if violated will result in even more drops to 27.56. On the upside, there is a resistance level at 28.34. A further resistance level may holdings at 28.56. The Relative Strength Index (RSI) on the 14-day chart is 41.26, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.36%. Stochastics %K at 20.12% indicates the stock is a holding.

Most Popular